CRISX
Price
$20.09
Change
+$0.04 (+0.20%)
Updated
Jul 31 closing price
Net Assets
73.2M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

CRISX vs VSMAX

CRISX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CRISX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRISX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. CRISX (73.2M). VSMAX pays higher dividends than CRISX: VSMAX (1.21) vs CRISX (0.69). CRISX was incepted earlier than VSMAX: CRISX (29 years) vs VSMAX (26 years). CRISX (1.08) is less costly to investors than VSMAX (0.05). CRISX is a more actively managed with annual turnover of: 38.00 vs. VSMAX (17.00). VSMAX has a lower initial minimum investment than CRISX: VSMAX (3000) vs CRISX (1000000). CRISX (22.76) and VSMAX (22.58) have marching annual gain over last year. VSMAX return over 5 years is better than : 35.11 vs. CRISX (3.90).
CRISXVSMAXCRISX / VSMAX
Total Expense Ratio1.080.052,160%
Annual Report Gross Expense Ratio1.080.052,160%
Fund Existence29 years26 years-
Gain YTD19.94014.588137%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets73.2M189B0%
Annual Yield % from dividends0.691.2157%
Returns for 1 year22.7622.58101%
Returns for 3 years26.1943.4260%
Returns for 5 years3.9035.1111%
Returns for 10 years17.47155.9611%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H